McKnight's Long-Term Care News1h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Alaska Dispatch News12hOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise The weight loss drug ...
This anti-diabetic drug used for weight loss has been approved by US FDA: When will India see its launch?
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...